Townsquare Capital LLC Decreases Stock Position in CVS Health Corporation $CVS

Townsquare Capital LLC lowered its position in shares of CVS Health Corporation (NYSE:CVS) by 19.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,696 shares of the pharmacy operator’s stock after selling 7,026 shares during the period. Townsquare Capital LLC’s holdings in CVS Health were worth $2,163,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CVS. Harbor Capital Advisors Inc. increased its position in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Avion Wealth raised its position in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Corundum Trust Company INC purchased a new position in shares of CVS Health during the 3rd quarter valued at approximately $29,000. Harbor Asset Planning Inc. acquired a new stake in CVS Health in the second quarter valued at $30,000. Finally, Front Row Advisors LLC grew its holdings in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS opened at $74.33 on Friday. CVS Health Corporation has a twelve month low of $53.36 and a twelve month high of $85.15. The stock has a market cap of $94.35 billion, a PE ratio of 195.61, a price-to-earnings-growth ratio of 0.68 and a beta of 0.48. The business’s 50 day moving average is $78.97 and its 200-day moving average is $75.01. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the firm posted $1.09 EPS. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CVS shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. The Goldman Sachs Group upped their price target on CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Leerink Partners increased their target price on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Raymond James Financial boosted their price objective on shares of CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Finally, Barclays raised their target price on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.